No effect ofn-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial
- 1 February 2008
- journal article
- research article
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 99 (2), 421-431
- https://doi.org/10.1017/s0007114507801097
Abstract
Low dietary intakes of the n-3 long-chain PUFA (LCPUFA) EPA and DHA are thought to be associated with increased risk for a variety of adverse outcomes, including some psychiatric disorders. Evidence from observational and intervention studies for a role of n-3 LCPUFA in depression is mixed, with some support for a benefit of EPA and/or DHA in major depressive illness. The present study was a double-blind randomised controlled trial that evaluated the effects of EPA+DHA supplementation (1.5 g/d) on mood and cognitive function in mild to moderately depressed individuals. Of 218 participants who entered the trial, 190 completed the planned 12 weeks intervention. Compliance, confirmed by plasma fatty acid concentrations, was good, but there was no evidence of a difference between supplemented and placebo groups in the primary outcome - namely, the depression subscale of the Depression Anxiety and Stress Scales at 12 weeks. Mean depression score was 8.4 for the EPA+DHA group and 9.6 for the placebo group, with an adjusted difference of - 1.0 (95 % CI - 2.8, 0.8; P = 0.27). Other measures of mood, mental health and cognitive function, including Beck Depression Inventory score and attentional bias toward threat words, were similarly little affected by the intervention. In conclusion, substantially increasing EPA+DHA intake for 3 months was found not to have beneficial or harmful effects on mood in mild to moderate depression. Adding the present result to a meta-analysis of previous relevant randomised controlled trial results confirmed an overall negligible benefit of n-3 LCPUFA supplementation for depressed mood.This publication has 43 references indexed in Scilit:
- Effects of n–3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trialsThe American Journal of Clinical Nutrition, 2006
- Anger Attacks in Depression – Evidence for a Male Depressive SyndromePsychotherapy and Psychosomatics, 2005
- Dietary intake of fatty acids and fish in relation to cognitive performance at middle ageNeurology, 2004
- Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trialEuropean Neuropsychopharmacology, 2003
- A Double-Blind, Placebo-Controlled Study of the Omega-3 Fatty Acid Docosahexaenoic Acid in the Treatment of Major DepressionAmerican Journal of Psychiatry, 2003
- Omega-3 Fatty Acid Treatment of Women With Borderline Personality Disorder: A Double-Blind, Placebo-Controlled Pilot StudyAmerican Journal of Psychiatry, 2003
- Depression and adipose essential polyunsaturated fatty acidsProstaglandins, Leukotrienes & Essential Fatty Acids, 2002
- A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in SchizophreniaAmerican Journal of Psychiatry, 2001
- The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety InventoriesBehaviour Research and Therapy, 1995
- Anxiety and the Allocation of Attention to ThreatThe Quarterly Journal of Experimental Psychology Section A, 1988